SCHEMBL19559130

SCHEMBL19559130

C=C(N)c1cc(C(=O)OC)c(CC)cc1C1CCC1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.34
KDM4E B2RXH2 4/20 0.34
ALDH1A1 P00352 4/20 0.34
HSD17B10 Q99714 3/20 0.34
TSHR P16473 2/20 0.34
OPRK1 P41145 5/20 0.34
PDK2 Q15119 1/20 0.32
PDK4 Q16654 1/20 0.32
CFTR P13569 1/20 0.32
PTGDR Q13258 1/20 0.32
PTGDR2 Q9Y5Y4 1/20 0.32
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
FASN P49327 2/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
YAP1 P46937 1/20 0.32
HTR2A P28223 2/20 0.32
OPRM1 P35372 1/20 0.31
GAA P10253 1/20 0.31
HPGD P15428 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12488116 0.87 ALDH1A1 (0.36) MAPTKDM4EALDH1A1HSD17B10TSHR
SCHEMBL19559124 0.84 FASN (0.42) MAPTKDM4EALDH1A1PDK2PDK4
SCHEMBL12489103 0.83 CAMKK2 (0.36) MAPTKDM4EALDH1A1HSD17B10TSHR
SCHEMBL18432260 0.81 PDK2 (0.37) MAPTKDM4EALDH1A1HSD17B10TSHR
SCHEMBL12488689 0.81 MEN1 (0.33) MAPTKDM4EALDH1A1HSD17B10TSHR
SCHEMBL12489172 0.80 CFTR (0.36) MAPTKDM4EALDH1A1HSD17B10TSHR
SCHEMBL19559110 0.79 SLC6A3 (0.42) MAPTKDM4EALDH1A1HSD17B10PDK2
SCHEMBL12488878 0.78 GAA (0.42) MAPTKDM4EALDH1A1KMT2AFASN
SCHEMBL12487977 0.77 PDK2 (0.38) MAPTKDM4EALDH1A1HSD17B10TSHR
SCHEMBL18432496 0.75 PDK2 (0.41) MAPTKDM4EALDH1A1HSD17B10TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11034690-B2 Heterocyclic modulators of lipid synthesis Saginiet Biosciences Inc. (US) 2021-06-15 US disclosed
US-20190308969-A1 HETEROCYCLIC MODULATORS OF LIPID SYNTHESIS SAGIMET BIOSCIENCES INC. 2019-10-10 US disclosed
US-9809591-B2 Heterocyclic modulators of lipid synthesis 3-V BIOSCIENCES, INC. (US) 2017-11-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11034690-B2 Heterocyclic modulators of lipid synthesis FASN, FADS1, SCD MAPT 4329/4885KDM4E 1740/4885ALDH1A1 724/4885
US-20190308969-A1 HETEROCYCLIC MODULATORS OF LIPID SYNTHESIS FASN, FADS1, SCD MAPT 4193/4885KDM4E 1619/4885ALDH1A1 687/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.